IRIS Accounts Production v26.1.10.61 08593620 Board of Directors 1.4.25 31.3.26 31.3.26 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh085936202025-03-31085936202026-03-31085936202025-04-012026-03-31085936202024-03-31085936202024-04-012025-03-31085936202025-03-3108593620ns15:EnglandWales2025-04-012026-03-3108593620ns14:PoundSterling2025-04-012026-03-3108593620ns10:Director12025-04-012026-03-3108593620ns10:PrivateLimitedCompanyLtd2025-04-012026-03-3108593620ns10:SmallEntities2025-04-012026-03-3108593620ns10:AuditExempt-NoAccountantsReport2025-04-012026-03-3108593620ns10:SmallCompaniesRegimeForDirectorsReport2025-04-012026-03-3108593620ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-3108593620ns10:FullAccounts2025-04-012026-03-3108593620ns10:Director22025-04-012026-03-3108593620ns10:RegisteredOffice2025-04-012026-03-3108593620ns5:CurrentFinancialInstruments2026-03-3108593620ns5:CurrentFinancialInstruments2025-03-3108593620ns5:ShareCapital2026-03-3108593620ns5:ShareCapital2025-03-3108593620ns5:RetainedEarningsAccumulatedLosses2026-03-3108593620ns5:RetainedEarningsAccumulatedLosses2025-03-3108593620ns5:FurnitureFittings2025-04-012026-03-3108593620ns5:ComputerEquipment2025-04-012026-03-3108593620ns5:FurnitureFittings2025-03-3108593620ns5:ComputerEquipment2025-03-3108593620ns5:FurnitureFittings2026-03-3108593620ns5:ComputerEquipment2026-03-3108593620ns5:FurnitureFittings2025-03-3108593620ns5:ComputerEquipment2025-03-3108593620ns5:WithinOneYearns5:CurrentFinancialInstruments2026-03-3108593620ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-31
REGISTERED NUMBER: 08593620 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026

FOR

NURSE EXPERT WITNESS LIMITED

NURSE EXPERT WITNESS LIMITED (REGISTERED NUMBER: 08593620)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


NURSE EXPERT WITNESS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2026







DIRECTORS: D Aslan
C Aslan





REGISTERED OFFICE: 30 Riverside Road
Shoreham-By-Sea
West Sussex
BN43 5RB





REGISTERED NUMBER: 08593620 (England and Wales)





ACCOUNTANTS: Galloways Accounting Limited
15 West Street
Brighton
East Sussex
BN1 2RL

NURSE EXPERT WITNESS LIMITED (REGISTERED NUMBER: 08593620)

BALANCE SHEET
31 MARCH 2026

2026 2025
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 25,647 30,576
Investment property 5 25,606 25,606
51,253 56,182

CURRENT ASSETS
Debtors 6 13,894 18,955
Cash at bank 44,271 18,988
58,165 37,943
CREDITORS
Amounts falling due within one year 7 39,936 37,619
NET CURRENT ASSETS 18,229 324
TOTAL ASSETS LESS CURRENT
LIABILITIES

69,482

56,506

PROVISIONS FOR LIABILITIES 4,875 -
NET ASSETS 64,607 56,506

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 64,605 56,504
SHAREHOLDERS' FUNDS 64,607 56,506

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 2 June 2026 and were signed on its behalf by:





D Aslan - Director


NURSE EXPERT WITNESS LIMITED (REGISTERED NUMBER: 08593620)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026


1. STATUTORY INFORMATION

Nurse Expert Witness Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover represents invoiced sales for the provision of nurse expert witness services to the legal sector net of VAT. Turnover is recognised upon the performance of that service.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance
Office equipment - 25% on reducing balance

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

Investment property
Investment property is initially recognised as cost and then subsequently at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation
Taxation for the year comprises current tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Financial instruments
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2025 - 2 ) .

NURSE EXPERT WITNESS LIMITED (REGISTERED NUMBER: 08593620)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2026


4. TANGIBLE FIXED ASSETS
Fixtures
and Office
fittings equipment Totals
£    £    £   
COST
At 1 April 2025 14,310 31,050 45,360
Additions - 2,660 2,660
At 31 March 2026 14,310 33,710 48,020
DEPRECIATION
At 1 April 2025 3,903 10,881 14,784
Charge for year 2,240 5,349 7,589
At 31 March 2026 6,143 16,230 22,373
NET BOOK VALUE
At 31 March 2026 8,167 17,480 25,647
At 31 March 2025 10,407 20,169 30,576

5. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 April 2025
and 31 March 2026 25,606
NET BOOK VALUE
At 31 March 2026 25,606
At 31 March 2025 25,606

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade debtors 13,524 18,600
Other debtors - 225
Prepayments and accrued income 370 130
13,894 18,955

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade creditors 330 1,710
Tax 22,826 11,447
VAT 8,783 6,893
Directors' current accounts 6,147 15,819
Accruals and deferred income 1,850 1,750
39,936 37,619